A 64-year-old with HFrEF (EF 32%) on ARNI, beta-blocker, MRA, and SGLT2i remains euvolemic. He asks about salt intake and BP targets for kidney protec...

Question

A 64-year-old with HFrEF (EF 32%) on ARNI, beta-blocker, MRA, and SGLT2i remains euvolemic. He asks about salt intake and BP targets for kidney protection. What CKD staging element also guides risk discussion and ACEI/ARB therapy?

Accepted Answer

Albuminuria category (A1-A3) using UACR

Answer

Only eGFR stage (G category) is needed

Answer

Serum uric acid level

Answer

Serum bicarbonate level

Answer

Cystatin C alone

us-abim MCQ (SBA): CKD Risk Stratification

A 64-year-old with HFrEF (EF 32%) on ARNI, beta-blocker, MRA, and SGLT2i remains euvolemic. He asks about salt intake and BP targets for kidney protection. What CKD staging element also guides risk discussion and ACEI/ARB therapy?